期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清ProGRP、TPS及NSE水平与小细胞肺癌的相关性研究 被引量：1

下载PDF
导出
摘要 目的研究分析血清ProGRP、TPS及NSE水平与小细胞肺癌的相关性,总结其临床意义。方法选取泰安市肿瘤医院2009年11月—2011年11月,经手术病检证实为小细胞肺癌的患者24例,设为观察组,再选择同期体检健康的受检者30例,设为对照组,分别对两组受检者进行血清ProGRP、TPS及NSE检测,观察对比两组检测结果。结果观察组血清ProGRP、TPS及NSE水平均显著高于对照组(P<0.05),具有统计学意义。结论血清ProGRP、TPS及NSE三种肿瘤标志物对于早期诊断小细胞肺癌有重要的临床应用价值,其中ProGRP属于疗效评价的敏感指标,检测血清ProGRP、TPS及NSE对监测病情进展和评估预后有重要的临床意义。
作者 陈宁
机构地区 山东省泰安市红十字会中心血站
出处 《中国卫生产业》 2013年第6期139-139,共1页 China Health Industry
关键词 PROGRP TPS NSE 预后
分类号 R515 [医药卫生—内科学]
  • 相关文献

参考文献2

二级参考文献17

  • 1Molina R,Filella X,Aug JM.ProGRP:a new biomarker for small cell lung cancer.Clin Biochem,2004,37:505-511.
  • 2Wójcik E,Kulpa JK,Sas-Korczy(n)ska B,et al.ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.Anticancer Res,2008,28:3027-3033.
  • 3Schneider J,Philipp M,Salewski L,et al.Pro-gastrin-releasing peptide and neuron specific enolase in therapy control of patients with small-cell lung cancer.Clin Lab,2003,49:35-42.
  • 4Shibayama T,Ueoka H,Nishii K,et al.Complementary roles of pro-gastrin-releasing peptide and neuron specific enolase in diagnosis and prognosis of small-cell lung cancer.Lung Cancer,2001,32:61-69.
  • 5Barak V,Goike H,Panaretakis KW,et al.Clinical utility of cytokeratins as tumor markers.Clin Biochem,2004,37:529-540.
  • 6Molina R,Augé JM,Bosch X,et al.Usefulness of serum tumor markers,including progastrin-releasing peptide,in patients with lung cancer:correlation with histology.Tumour Biol,2009,30:121-129.
  • 7Yasasever V,Dincer M,Camlica H,et al.Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastasis:special emphasis on "spiking" phenomena.Clin Biochem,1997,30:53-56.
  • 8Pentheroudakis G,Malamou-Mitsi V,Briasoulis E,et al.The neutrophil,not the tumor:serum CA 15-3 elevation as a result of granulocyte-colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.Cancer,2004,101:1767-1775.
  • 9Niho S, Nishiwaki Y, Goto K. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative e- valuation with neuron-specific enolase and carcino-embryonic antigen [J].Lung Cancer,2000;27(3) :159-67.
  • 10Molina R, Auge JM, Filella X. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC. CYFRA 21-1 and NSE in patients with lung cancer[ J]. Anticancer Res,2005 ;25 ( 3 ) : 1773-8.

共引文献30

同被引文献43

  • 1王中原,陈光辉.神经元特异性烯醇化酶与脑损伤[J].医学研究生学报,2000,13(4):250-253. 被引量：8
  • 2Brandner S,Thaler C. Brain-derived protein concentra- tions in the cerebrospinal fluid:Contribution of trauma re- suiting from ventrieular drain insertion[J]. Journal of Neu- rotrauma, 2013,30(13) : 1205-1210.
  • 3Li X, Asmitananda T, Gao L, et al. Biomarkers in the lung cancer diagnosis:a clinical perspective [J]. Neoplasma,2011,59(5):500-507.
  • 4Orlino EN,Olmstead CE. An enzyme immunoassay for neu- ron-specific enolase in cerebrospinal fluid [J]. Biochem Mol Med, 1997,61 ( 1 ) : 41-46.
  • 5Tracy MR. Evolutionary history of the enolase gene family [J]. Gene, 2000,259(1-2) : 129-138.
  • 6Chai G. Expression, purification and the 1.8 angstroms resolution crystal structure of human neuron specific eno- lase [J]. Mol Biol,2004,341(4) : 1015-1021.
  • 7Hein-Nae MK,KShler A,Diem R,et al. Biological mark- ers for ax- onal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis [J]. Neurosei Lett, 2008,436 ( 1 ) : 72-76.
  • 8Papa L, Ramia MM,Kelly JM. Systematic review of clini- cal research on biomarkers for pediatric traumatic brain injury [J]. Neurotrauma, 2013,30(5) :324-338.
  • 9Chaves ML,Ferreira ED. Serum levels of SIOOB and NSE proteins in Alzheimer's disease patients [J]. Journal of Neuroinflammation, 2010,7 ( 1 ) : 1-7.
  • 10Singh, Harsh V,Aparna P, et al. Prognostic value of neu- ron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit [J]. Clinica Chimica Acta, 2013,419 (complete) : 136-138.

引证文献1

二级引证文献14

中国卫生产业
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部